نتایج جستجو برای: ruthenium compounds

تعداد نتایج: 234102  

Journal: :Journal of Synthetic Organic Chemistry, Japan 1988

2014
Hernan A. Retamales Tanya Scharaschkin

UNLABELLED PREMISE OF THE STUDY Here we propose a staining protocol using toluidine blue (TBO) and ruthenium red to reliably identify secondary compounds in the leaves of some species of Myrtaceae. • METHODS AND RESULTS Leaves of 10 species representing 10 different genera of Myrtaceae were processed and stained using five different combinations of ruthenium red and TBO. Optimal staining c...

2008
Nicolas P.E. Barry Padavattan Govindaswamy Julien Furrer Georg Süss-Fink Bruno Therrien

s Ruthenium Supramolecular chemistry Cage compounds ridyl)p

2017
Ivan Kajan Teemu Kärkelä Ari Auvinen Christian Ekberg

Ruthenium is a fission product that can be released from the fuel in case of a severe nuclear accident. In this work the impact of the atmosphere composition, including air radiolysis products, on the transport of ruthenium through a primary circuit was examined. Experiments were performed at temperatures 1300, 1500 and 1700 K in a slightly humid air. In the experiments significant effect of ni...

Journal: :Antimicrobial agents and chemotherapy 2013
Fabienne Barna Karim Debache Carsten A Vock Tatiana Küster Andrew Hemphill

Upon the screening of 16 antiproliferative compounds against Toxoplasma gondii and Neospora caninum, two hydrolytically stable ruthenium complexes (compounds 16 and 18) exhibited 50% inhibitory concentrations of 18.7 and 41.1 nM (T. gondii) and 6.7 and 11.3 nM (N. caninum). To achieve parasiticidal activity with compound 16, long-term treatment (22 to 27 days at 80 to 160 nM) was required. Tran...

2013
Shyam Sunder A Satyavati Dhulipala Sreekanth Thota Rajeshwar Yerra Jan Balzarini Erik De Clercq

BACKGROUND From the thousands of years, metal compounds have been used in medicine for treatment of various diseases including various types of cancers. Ruthenium was seen as a promising metal due to its similar kinetics to platinum and its lower toxicity. Therefore, we aimed to evaluate the newer mononuclear ruthenium (II) compounds for antinociceptive and antitumor activities. MATERIALS AND...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2012
Shyam Sunder Anchuri Sreekanth Thota Rajeshwar Yerra Krishna Prasad Devarakonda Satyavathi Dhulipala

The present study was conducted to evaluate in vivo anticancer activity of two novel mononuclear ruthenium(II) compounds, namely Ru(1,10-phenanthroline)2(2-nitro phenyl thiosemicarbazone)Cl2 (Compound R1) and Ru (1,10-phenanthroline)2(2-hydroxy phenyl thiosemicarbazone)Cl2 (Compound R2) against Ehrlich ascites carcinoma (EAC) mice and in vitro cytotoxic activity against IEC-6 (small intestine) ...

Journal: :Physical chemistry chemical physics : PCCP 2011
Iker del Rosal Torsten Gutmann Bernadeta Walaszek Iann C Gerber Bruno Chaudret Hans-Heinrich Limbach Gerd Buntkowsky Romuald Poteau

It is now well-known that (2)H solid-state NMR techniques can bring a better understanding of the interaction of deuterium with metal atoms in organometallic mononuclear complexes, clusters or nanoparticles. In that context, we have recently obtained experimental quadrupolar coupling constants and asymmetry parameters characteristic of deuterium atoms involved in various bonding situations in r...

Journal: :Applied Biosciences 2022

This review addresses the search for activity enhancement of leishmanicidal organic compounds through their coordination chemistry with ruthenium. In an introduction to leishmaniasis, its clinical manifestations, geographical distribution, available forms treatment, and challenges disease management are presented. Ruthenium complexes, owing physico-chemical biological properties, introduced as ...

Journal: :Chemistry 2010
Olivier Zava Johan Mattsson Bruno Therrien Paul J Dyson

One of the main challenges in cancer chemotherapy is to develop drugs that selectively target cancer cells in order to reduce general toxicity and consequently side effects. One such targeting method involves using large carrier compounds that release a drug once inside a cancer cell, since large compounds selectively accumulate in cancer tissue due to the “enhanced permeability and retention e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید